Evaluation of the safety of a protocol for switching venom immunotherapy products

Venom immunotherapy (VIT) in patients allergic to hymenoptera stings is clearly acknowledged as effective and safe. Safety, in particular, is a pivotal issue that requires the use of standardized products and well-established protocols for the build-up and maintenance phases of VIT1.

http://ift.tt/2EBnBkC